ImmunityBio, Inc. (IBRX) NASDAQ
7.52
-0.2(-2.59%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.82B |
| Enterprise Value | 2.61B |
| P/E Ratio | -9.04 |
| PEG Ratio | 0.07 |
| Price/Sales Ratio | 55.87 |
| Price/Book Ratio | -8.88 |
| Enterprise/Revenue | 62.39 |
| Enterprise/EBITDA | -45.87 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -6.06 |
| Operating Margin | -1.85 |
Management Effectiveness
| Return On Assets | -1.32 |
| Return On Equity | 1.39 |
Income Statement
| Revenue | 113.29M |
| Revenue/Share | 0.14 |
| Gross Profit | 112.54M |
| EBITDA | -223.56M |
| Net Income | -351.4M |
| Diluted EPS | -0.38 |
Balance Sheet
| Total Cash | 380.88M |
| Total Cash/Share | 0.37 |
| Total Debt | 1.12B |
| Total Debt/Equity | -1.29 |
| Current Ratio | 6.67 |
| Book Value Per Share | -0.85 |
Price History
| 52-Week Change | 182.71 |
| 52-Week High | 12.43 |
| 52-Week Low | 1.95 |
| Moving Average 50 Days | 7.69 |
| Moving Average 200 Days | 4.8 |
Statistics
| Average Volume | 19.01M |
| Shares Outstanding | 1.05B |
| % Held by Institutions | 19.34 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
